Liver cancer: Lipid synthesis promotes tumor formation
New publication in Cancer Cell: Protein mTOR stimulates the production of lipids in liver tumors.
New publication in Cancer Cell: Protein mTOR stimulates the production of lipids in liver tumors.
Nature paper by the Loewith group on new TORC1 structure in cells. Congratulations!
Researchers funded by the SNSF have discovered a biological clock at work in our muscle cells. It could be a factor in regulating our metabolism and play a role in diabetes.
The work of Hall has led to a fundamental change in how one thinks of cell growth and has provided critical information for the development of anti-cancer drugs. The Lasker Award is known as the highest award in medical sciences in the US.
A breakthrough for the general pipeline of biosensors : a new antibody-linked biosensor can identify a synthetic drug in a patient’s blood sample.
Development of high-performance synthetic binding proteins, termed monobodies, that prove to be effectively and specifically targeted to the SH2 domains of SFKs.
Combining an anticancer drug with an antirheumatic produces improved effects against tumors. The discovery, co-funded by the NCCR Chemical Biology, opens a new path for drug-drug synergy.
The collaborative efforts of two NCCR groups, the Riezman lab and the Zumbühl group, were recently reported in Chemical Science.
Nour Lydia Mozaffari has been granted the Best Master Thesis Award 2017 for her work entitled: “Superresolution imaging of the TORC1 focus in Saccharomyces cerevisiae”.
The company can now carry out clinical trials on its new cancer treatment which has shown excellent efficacy in laboratory tests, and the company has filed several patents.